Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03708029 · ClinicalTrials.gov registry record · NA
Efficacy of Human Placental Graft in Diabetic Foot Ulcers
A NA study, sponsored by StimLabs.
- Terminated
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT03708029: Clinical Trial NA study, sponsored by StimLabs.
NCT03708029 is a NA study that was terminated before completion, run by StimLabs. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03708029, a NA study, was terminated before completion, sponsored by StimLabs.
- TERMINATED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
To determine the efficacy of full-thickness placental allograft in chronic wound healing
Primary Outcome
100% epithelization
Interventions
- OTHER Revita Allograft
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2018-11-13 |
| Est. Completion | 2019-12-01 |
| Phase | NA |
Why NCT03708029 stopped before completion
NCT03708029 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Revita Allograft is the first listed.
NCT03708029 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03708029 about?
NCT03708029 is a clinical study titled "Efficacy of Human Placental Graft in Diabetic Foot Ulcers". To determine the efficacy of full-thickness placental allograft in chronic wound healing
What is the current status of trial NCT03708029?
This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2018-11-13. Estimated completion is 2019-12-01.
What interventions are being tested in trial NCT03708029?
The interventions under investigation include: Revita Allograft (OTHER).
Who is sponsoring clinical trial NCT03708029?
This trial is sponsored by StimLabs, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03708029's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI